| Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR (NCT06297772) | Ruijin Hospital | 2024-06-01 |
| Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer: (NCT06411171) | xiaohua li | 2024-06-01 |
| Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult (NCT06370442) | State University of New York - Upstate Medical University | 2024-06-01 |
| Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery (NCT05965492) | University of Miami | 2024-06-01 |
| A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain (NCT06814535) | Cairo University | 2024-06-01 |
| Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension (NCT06683040) | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 2024-06-01 |
| Efficacy of Different Agents in Treatment of Initial Caries on Smooth Surfaces in Permanent Teeth in Children (NCT05206539) | Plovdiv Medical University | 2024-06-01 |
| A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma (NCT06465446) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2024-06-01 |
| Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery (NCT06414330) | Assiut University | 2024-06-01 |
| To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial (NCT06454773) | Diabetes Foundation, India | 2024-06-01 |
| Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC) (NCT07403266) | Oils4Cure | 2024-06-01 |
| Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia (NCT05456152) | EMS | 2024-06-01 |
| Opioid Free Versus Opioid Balanced Anesthesia in Ophthalmic Surgery (NCT06382831) | Indonesia University | 2024-06-01 |
| Nutrition Impact on Immunotherapy of Cancer (NCT06500234) | Qingdao Central Hospital | 2024-06-01 |
| Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion (NCT06089369) | Tongji Hospital | 2024-06-01 |
| Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. (NCT06482554) | Louisiana State University Health Sciences Center Shreveport | 2024-06-01 |
| Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia (NCT06491108) | Tanta University | 2024-06-01 |
| The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension (NCT06473493) | Shanghai Changzheng Hospital | 2024-06-01 |
| MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction (NCT06191965) | Mclean Hospital | 2024-06-01 |
| Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer (NCT06443671) | Peking University Cancer Hospital & Institute | 2024-06-01 |
| A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin (NCT06440824) | Shandong University | 2024-06-01 |
| Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke (NCT05892510) | University of Melbourne | 2024-06-01 |
| Benefits of Inhalation of Hypertonic Saline Solution Prior to Physiotherapy ELTGOL Technique in Bronchiectasis (NCT06443658) | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | 2024-06-01 |
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage (NCT05627752) | Zhongnan Hospital | 2024-06-01 |
| Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast (NCT06340984) | South Valley University | 2024-06-01 |
| Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients (NCT06007586) | Sichuan Cancer Hospital and Research Institute | 2024-05-31 |
| Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein (NCT06093503) | AbbVie | 2024-05-31 |
| Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care (NCT06556550) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2024-05-31 |
| A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma (NCT06261957) | GlaxoSmithKline | 2024-05-31 |
| Global Study of Del-desiran for the Treatment of DM1 (NCT06411288) | Avidity Biosciences, Inc. | 2024-05-30 |
| Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial (NCT06438627) | XIANG YANQUN | 2024-05-30 |
| Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) (NCT05804370) | NX Development Corp | 2024-05-30 |
| Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China (NCT06422117) | Haisco Pharmaceutical Group Co., Ltd. | 2024-05-30 |
| Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer (NCT06490328) | Dongkook Pharmaceutical Co., Ltd. | 2024-05-30 |
| The Role of SGLT2i in Management of Moderate AS (NCT06469645) | University of East Anglia | 2024-05-30 |
| ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) (NCT06373731) | Stealth BioTherapeutics Inc. | 2024-05-30 |
| Seasonal R21 Mass Vaccination for Malaria Elimination (NCT06578572) | London School of Hygiene and Tropical Medicine | 2024-05-30 |
| Dural Medical Adhesive for Watertight Sealing in Dural Repair (NCT07754344) | Medprin Regenerative Medical Technologies Co., Ltd. | 2024-05-29 |
| A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). (NCT06412666) | Cytokinetics | 2024-05-29 |
| A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL (NCT06363994) | InnoCare Pharma Inc. | 2024-05-29 |
| A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema (NCT06422507) | Bayer | 2024-05-29 |
| Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers (NCT06435221) | Achieve Life Sciences | 2024-05-28 |
| A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines (NCT06946160) | Espad Pharmed | 2024-05-28 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD (NCT06359899) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2024-05-28 |
| A Study of Pitolisant in Patients With Prader-Willi Syndrome (NCT06366464) | Harmony Biosciences Management, Inc. | 2024-05-28 |
| BHV-7000 Acute Treatment of Bipolar Mania (NCT06419582) | Biohaven Therapeutics Ltd. | 2024-05-28 |
| A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED) (NCT06329791) | Azura Ophthalmics | 2024-05-28 |
| A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT06417008) | Hansoh BioMedical R&D Company | 2024-05-28 |
| A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX) (NCT06260748) | Leadiant Biosciences, Inc. | 2024-05-27 |
| Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients (NCT06364072) | Cessatech A/S | 2024-05-27 |
| ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients (NCT06195709) | Institut Curie | 2024-05-27 |
| Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain (NCT06160778) | University of Calgary | 2024-05-27 |
| Multi-Center Clean Air Randomized Controlled Trial in COPD (NCT06376994) | JHSPH Center for Clinical Trials | 2024-05-24 |
| IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency (NCT06434025) | Hospital de Clinicas de Porto Alegre | 2024-05-24 |
| A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (NCT06419374) | 89bio, Inc. | 2024-05-24 |
| MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction) (NCT05974462) | University Hospital, Antwerp | 2024-05-24 |
| A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) (NCT06345729) | Merck Sharp & Dohme LLC | 2024-05-24 |
| Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer (NCT06441565) | Sun Yat-sen University | 2024-05-24 |
| Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis. (NCT07549386) | Laboratorios Liomont | 2024-05-24 |
| Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism (NCT06362746) | Supergene, LLC | 2024-05-23 |
| Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population (NCT05926258) | Sintetica SA | 2024-05-23 |
| A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis (NCT06390722) | AbbVie | 2024-05-23 |
| A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) (NCT06384547) | Viridian Therapeutics, Inc. | 2024-05-23 |
| A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) (NCT06351631) | Merck Sharp & Dohme LLC | 2024-05-23 |
| CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes (NCT05931276) | VA Office of Research and Development | 2024-05-22 |
| A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01) (NCT06382116) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-05-22 |
| Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). (NCT06133972) | Novartis Pharmaceuticals | 2024-05-21 |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (NCT06203210) | Daiichi Sankyo | 2024-05-21 |
| A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy (NCT06220773) | Boryung Pharmaceutical Co., Ltd | 2024-05-21 |
| Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus (NCT06952231) | University of Lahore | 2024-05-21 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome (NCT06118255) | UCB BIOSCIENCES, Inc. | 2024-05-21 |
| Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (NCT06347133) | Arrowhead Pharmaceuticals | 2024-05-21 |
| Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia (NCT06607419) | Shanghai Jiao Tong University School of Medicine | 2024-05-21 |
| Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients (NCT05735834) | International Extranodal Lymphoma Study Group (IELSG) | 2024-05-21 |
| Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine (NCT06531707) | Laboratorios Silanes S.A. de C.V. | 2024-05-20 |
| Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus (NCT06135259) | Ain Shams University | 2024-05-20 |
| Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris (NCT06403501) | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | 2024-05-20 |
| VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT06237452) | Vedanta Biosciences, Inc. | 2024-05-20 |
| Phase III Study to Evaluate the Efficacy and Safety of AD-209 (NCT06348576) | Addpharma Inc. | 2024-05-20 |
| To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome (NCT06388070) | Huons Co., Ltd. | 2024-05-20 |
| [68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma (NCT06125028) | Pentixapharm AG | 2024-05-20 |
| Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (NCT06307665) | AstraZeneca | 2024-05-20 |
| Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma (NCT06158841) | AbbVie | 2024-05-19 |
| A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02) (NCT06382129) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-05-17 |
| Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes (NCT06520839) | University Medical Centre Ljubljana | 2024-05-17 |
| Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma (NCT06516133) | Sun Yat-sen University | 2024-05-17 |
| Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia (NCT05840822) | Avecho Biotechnology | 2024-05-16 |
| A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque (NCT06305559) | NewAmsterdam Pharma | 2024-05-16 |
| Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis. (NCT06383780) | XIANG YANQUN | 2024-05-15 |
| Evaluating Emetine for Viral Outbreaks (EVOLVE) (NCT05889793) | Johns Hopkins University | 2024-05-15 |
| An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO (NCT06299982) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-05-15 |
| A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy (NCT06383702) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-05-15 |
| A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis (NCT06293053) | Sanofi | 2024-05-15 |
| Melatonin for Pulmonary Hypertension in Full Term Neonates (NCT06685679) | Ain Shams University | 2024-05-15 |
| Clinical and Radiographic Evaluation of The Effect of Acetal Resin Versus PEEK on Supporting Structure of Abutment Teeth (NCT06882161) | Al-Azhar University | 2024-05-15 |
| Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer (NCT06250972) | Fudan University | 2024-05-15 |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT06411899) | MoonLake Immunotherapeutics AG | 2024-05-15 |
| ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03) (NCT06378138) | Beijing InnoCare Pharma Tech Co., Ltd. | 2024-05-15 |
| Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC (NCT06188715) | Jennifer Keiser | 2024-05-14 |
| Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP (NCT06079359) | Alexion Pharmaceuticals, Inc. | 2024-05-14 |